Stocks
Regencell Bioscience Holdings LimitedRGC
NASDAQHealthcareBiotechnology$5.64-3.21%
Price as of · delayed, not real-time
Specializing in traditional Chinese medicine, this biopharmaceutical company develops treatments for neurocognitive disorders and ADHD. Its $11.5B valuation reflects investor interest in alternative therapies with large addressable markets.
Market Cap: $11.5B52W Range: $4.51-$69.00
Congressional Interest in Regencell Bioscience Holdings Limited (RGC)
7 members of Congress have disclosed 19 trades in Regencell Bioscience Holdings Limited (RGC), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 14 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
19
Unique Politicians
7
Buys
5
Sells
14
Who in Congress Is Trading RGC?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-01-09 | Lois Frankel | sell | $1K-$15K |
| 2018-01-08 | Lois Frankel | sell | $1K-$15K |
| 2017-12-08 | Lois Frankel | sell | $1K-$15K |
| 2017-12-08 | Michael F Bennet | sell | $500K-$1M |
| 2017-06-01 | JAMES B. RENACCI | sell | $500K-$1M |
| 2017-04-04 | Gary Palmer | buy | $1K-$15K |
| 2017-03-28 | Michael F Bennet | sell | $500K-$1M |
| 2017-01-26 | JAMES B. RENACCI | sell | $1K-$15K |
| 2016-11-08 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2015-09-22 | JAMES B. RENACCI | sell | $15K-$50K |
| 2015-08-19 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2015-03-18 | JAMES B. RENACCI | buy | $1K-$15K |
| 2011-02-05 | JAMES B. RENACCI | sell | $30,783.88 |
| 2010-02-06 | JAMES B. RENACCI | buy | $6,159.49 |
| 2008-08-01 | Lamar Smith | sell | $3,708.53 |
| 2008-08-01 | Lamar Smith | sell | $3,708.47 |
| 2008-08-01 | Lamar Smith | sell | $1,585.76 |
| 2001-11-12 | ALAN S. LOWENTHAL | buy | $1K-$15K |
| 2001-08-08 | Lamar Smith | sell | $3,708.47 |